Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty

This double-blind, randomized study evaluated the effect of nifedipine on restenosis after coronary angioplasty. Two hundred forty-one patients with dilation of 271 coronary sites were randomized at the time of hospital discharge to receive nifedipine, 10 mg (123 patients), or placebo (118 patients) four times daily for 6 months. No patient was known to have coronary artery spasm. The mean duration of therapy was 4.4 +/- 2 (mean +/- SD) months for nifedipine and 4.3 +/- 2 months for placebo. A restudy angiogram was available in 100 patients (81%) in the nifedipine group and 98 patients (83%) in the placebo group. A recurrent coronary stenosis was noted in 28% of patients in the nifedipine group and in 29.5% of those in the placebo group (p = NS). The mean diameter stenosis was 36.4 +/- 23% for the nifedipine group and 36.7 +/- 23% for the placebo group (p = NS). By pill count, 78% of patients receiving nifedipine and 82% of those receiving placebo complied with the study drug regimen. Coronary stenosis recurred in 33% of patients in the placebo group and in 29% of patients in the nifedipine group who complied with the regimen and had angiograms (p = NS). In conclusion, the study did not demonstrate a significant beneficial effect of nifedipine on the incidence of recurrent stenosis after successful percutaneous transluminal coronary angioplasty.

This article has been cited by other articles:

				H.-P. Bestehorn, F.-J. Neumann, H. J. Buttner, P. Betz, P. Sturzenhofecker, E. von Hodenberg, A. Verdun, L. Levai, J. P. Monassier, and H. Roskamm Evaluation of the effect of oral verapamil on clinical outcome and angiographic restenosis after percutaneous coronary intervention: The randomized, double-blind, placebo-controlled, multicenter verapamil slow-release for prevention of cardiovascular events after angioplasty (VESPA) trial J. Am. Coll. Cardiol., June 16, 2004; 43(12): 2160 - 2165. [Abstract] [Full Text] [PDF]

				P. H. Stone, A. U. Coskun, S. Kinlay, M. E. Clark, M. Sonka, A. Wahle, O. J. Ilegbusi, Y. Yeghiazarians, J. J. Popma, J. Orav, et al. Effect of Endothelial Shear Stress on the Progression of Coronary Artery Disease, Vascular Remodeling, and In-Stent Restenosis in Humans: In Vivo 6-Month Follow-Up Study Circulation, July 29, 2003; 108(4): 438 - 444. [Abstract] [Full Text] [PDF]

				G. Sopko Preventing Cardiac Events and Restenosis After Percutaneous Coronary Intervention JAMA, June 26, 2002; 287(24): 3259 - 3261. [Full Text] [PDF]

				E. A. Rosenthal, T. J. Bohlmeyer, E. Monnet, C. MacPhail, A. D. Robertson, M. A. Horwitz, J. E.B. Burchenal, and L. D. Horwitz An Iron-Binding Exochelin Prevents Restenosis Due to Coronary Artery Balloon Injury in a Porcine Model Circulation, October 30, 2001; 104(18): 2222 - 2227. [Abstract] [Full Text] [PDF]

				M.Y Salame, S Verheye, I.R Crocker, N.A.F Chronos, K.A Robinson, and S.B King III Intracoronary radiation therapy Eur. Heart J., April 2, 2001; 22(8): 629 - 647. [PDF]

				M. V. Autieri, C. Carbone, and A. Mu Expression of Allograft Inflammatory Factor-1 Is a Marker of Activated Human Vascular Smooth Muscle Cells and Arterial Injury Arterioscler Thromb Vasc Biol, July 1, 2000; 20(7): 1737 - 1744. [Abstract] [Full Text] [PDF]

				B. Jorgensen, S. Simonsen, K. Endresen, K. Forfang, K. Vatne, J. Hansen, J. Webb, C. Buller, G. Goulet, J. Erikssen, et al. Restenosis and clinical outcome in patients treated with amlodipine after angioplasty: results from the coronary AngioPlasty Amlodipine REStenosis Study (CAPARES) J. Am. Coll. Cardiol., March 1, 2000; 35(3): 592 - 599. [Abstract] [Full Text] [PDF]

				M. Labinaz, K. Pels, C. Hoffert, S. Aggarwal, and E. R O'Brien Time course and importance of neoadventitial formation in arterial remodeling following balloon angioplasty of porcine coronary arteries Cardiovasc Res, January 1, 1999; 41(1): 255 - 266. [Abstract] [Full Text] [PDF]

				A. J. Lansky, G. S. Mintz, J. J. Popma, A. D. Pichard, K. M. Kent, L. F. Satler, D. S. Baim, R. E. Kuntz, C. Simonton, R. M. Bersin, et al. Remodeling after directional coronary atherectomy (with and without adjunct percutaneous transluminal coronary angioplasty): a serial angiographic and intravascular ultrasound analysis from the optimal atherectomy restenosis study J. Am. Coll. Cardiol., August 1, 1998; 32(2): 329 - 337. [Abstract] [Full Text] [PDF]

				S. J. George, J. L. Johnson, G. D. Angelini, and J. Y. Jeremy Short-term Exposure to Thapsigargin Inhibits Neointima Formation in Human Saphenous Vein Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 2500 - 2506. [Abstract] [Full Text]

				R. Altstidl, C. Goth, H. Lehmkuhl, K. Bachmann, and R. Altstidl Quantitative Angiographic Analysis of PTCA-Induced Coronary Vasoconstriction in Single-Vessel Coronary Artery Disease Angiology, October 1, 1997; 48(10): 863 - 870. [Abstract] [PDF]

				L. A. Guzman, V. Labhasetwar, C. Song, Y. Jang, A. M. Lincoff, R. Levy, and E. J. Topol Local Intraluminal Infusion of Biodegradable Polymeric Nanoparticles: A Novel Approach for Prolonged Drug Delivery After Balloon Angioplasty Circulation, September 15, 1996; 94(6): 1441 - 1448. [Abstract] [Full Text]

				G. S. Mintz, J. J. Popma, A. D. Pichard, K. M. Kent, L. F. Satler, S. Chiu Wong, M. K. Hong, J. A. Kovach, and M. B. Leon Arterial Remodeling After Coronary Angioplasty : A Serial Intravascular Ultrasound Study Circulation, July 1, 1996; 94(1): 35 - 43. [Abstract] [Full Text]

				S. B. King III Angioplasty From Bench to Bedside to Bench Circulation, May 1, 1996; 93(9): 1621 - 1629. [Full Text]

				L. A. Guzman, M. J. Mick, A. M. Arnold, F. Forudi, and P. L. Whitlow Role of Intimal Hyperplasia and Arterial Remodeling After Balloon Angioplasty : An Experimental Study in the Atherosclerotic Rabbit Model Arterioscler Thromb Vasc Biol, March 1, 1996; 16(3): 479 - 487. [Abstract] [Full Text]

				R. L. Geary, N. Koyama, T. W. Wang, S. Vergel, and A. W. Clowes Failure of Heparin to Inhibit Intimal Hyperplasia in Injured Baboon Arteries : The Role of Heparin-Sensitive and -Insensitive Pathways in the Stimulation of Smooth Muscle Cell Migration and Proliferation Circulation, June 15, 1995; 91(12): 2972 - 2981. [Abstract] [Full Text]

				C. Rogers and E. R. Edelman Endovascular Stent Design Dictates Experimental Restenosis and Thrombosis Circulation, June 15, 1995; 91(12): 2995 - 3001. [Abstract] [Full Text]

				R. Waksman, K. A. Robinson, I. R. Crocker, M. B. Gravanis, G. D. Cipolla, and S. B. King III Endovascular Low-Dose Irradiation Inhibits Neointima Formation After Coronary Artery Balloon Injury in Swine : A Possible Role for Radiation Therapy in Restenosis Prevention Circulation, March 1, 1995; 91(5): 1533 - 1539. [Abstract] [Full Text]

				G. L. Nunes, D. S. Sgoutas, R. A. Redden, S. R. Sigman, M. B. Gravanis, S. B. King III, and B. C. Berk Combination of Vitamins C and E Alters the Response to Coronary Balloon Injury in the Pig Arterioscler Thromb Vasc Biol, January 1, 1995; 15(1): 156 - 165. [Abstract] [Full Text]

				D. L. Fischman, M. B. Leon, D. S. Baim, R. A. Schatz, M. P. Savage, I. Penn, K. Detre, L. Veltri, D. Ricci, M. Nobuyoshi, et al. A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery Disease N. Engl. J. Med., August 25, 1994; 331(8): 496 - 501. [Abstract] [Full Text]

				C. Landau, R. A. Lange, and L. D. Hillis Percutaneous Transluminal Coronary Angioplasty N. Engl. J. Med., April 7, 1994; 330(14): 981 - 993. [Full Text]

				J. B. Wong, F. A. Sonnenberg, D. N. Salem, and S. G. Pauker Myocardial Revascularization for Chronic Stable Angina: Analysis of the Role of Percutaneous Transluminal Coronary Angioplasty Based on Data Available in 1989 Ann Intern Med, December 1, 1990; 113(11): 852 - 871. [Abstract] [PDF]

				J. J. Popma and G. J. Dehmer Care of the Patient after Coronary Angioplasty Ann Intern Med, April 1, 1989; 110(7): 547 - 559. [Abstract] [PDF]